Extracorporeal Membrane Oxygenation Market, Share, Growth, Trends and Forecast to 2032: Global Market Insights

1
Extracorporeal Membrane Oxygenation Market
Research Report Analysis and Forecasts to 2032
2

• Industry Insights

• The prevalence of respiratory and cardiovascular
  illnesses has increased dramatically throughout
  the European region in recent years, and this
  trend is expected to continue over the forecast
  time.
• An increase in CVD cases has led to introduction
  of government measures and implementation of
  different programs in the area to raise public
  awareness.
• Government funding for infrastructure development
  in emerging nations would help make expensive
  machines more accessible, which will boost
  industry revenue growth.
• For instance, in January 2021, Braile Biomedica,
  in collaboration with the Eldorado Institute and
  Embrapii, introduced the SOLIS System, a
  nationwide product against COVID-19.
• Extracorporeal membrane oxygenation (ECMO), a
  type of extracorporeal breathing, makes up the
  system. The corporation has benefited from such
  product introductions in securing its market
  position.

3

• Based on approach, the veno-venous (VV) segment
  held more than 180 million in 2022. The
  veno-venous ECMO device increases blood flow and
  oxygen levels while reducing cardiac effort and
  supporting hemodynamics.
• There will likely be a rise in demand for
  veno-venous ECMO through the forecast years due
  to the growing burden of cardiopulmonary
  diseases.
• With respect to type, the respiratory segment is
  poised to grow at more than 3 CAGR from 2023 to
  2032. A significant factor in the segment's
  growth is the risk of respiratory failure among
  individuals with different respiratory illnesses.
  
• Besides, the expanding geriatric population that
  is vulnerable to respiratory ailments, would
  further complement the growing market landscape.

4

• Regional Analysis

• From the regional front, the Latin America
  extracorporeal membrane oxygenation (ECMO) market
  is estimated to grow at more than 4 CAGR from
  2023 to 2032. The expansion is fueled by the
  burgeoning use of cutting-edge ECMO technology in
  healthcare settings in LATAM nations along with
  the region's rising respiratory and cardiac
  disease rates.

• Competitive Analysis

• The global extracorporeal membrane oxygenation
  market consists of several players including
  Abbott Laboratories, Fresenius Medical Care AG
  Co. KGaA, Braile Biomedica, Edwards Lifesciences
  Corporation, Abiomed, Eurosets, Getinge AB,
  LivaNova PLC, Medtronic, MicroPort Scientific
  Corporation, Nipro, SB-Kawasumi Laboratories,
  Inc., Spectrum Medical, and Terumo Corporation,
  among others.

5
Extracorporeal Membrane Oxygenation Market _at_
https//www.gminsights.com/industry-analysis/extra
corporeal-membrane-oxygenation-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/2
720
Request for customization _at_ https//www.gminsights
.com/roc/2720
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com